^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

modafinil

i
Other names: AFT-801, CN 801, CRL 40476
Company:
Generic mfg.
Drug class:
α1 adrenergic receptor agonist
3ms
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) (clinicaltrials.gov)
P2, N=361, Active, not recruiting, Duke University | Trial completion date: Dec 2025 --> Apr 2026 | Recruiting --> Active, not recruiting
Enrollment closed • Trial completion date
|
modafinil
3ms
RECOVER-SLEEP: Platform Protocol (clinicaltrials.gov)
P2, N=830, Completed, Duke University | Recruiting --> Completed
Trial completion
|
modafinil
3ms
Modafinil and Cognitive Function in POTS (clinicaltrials.gov)
P1, N=20, Active, not recruiting, Vanderbilt University Medical Center | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Dec 2026
Trial completion date • Trial primary completion date
|
modafinil
3ms
MODIFY: Modafinil to Improve Fatiguability (clinicaltrials.gov)
P1/2, N=40, Recruiting, Ottawa Hospital Research Institute | Not yet recruiting --> Recruiting | Phase classification: P3 --> P1/2 | Trial completion date: Mar 2026 --> Mar 2028 | Trial primary completion date: Mar 2026 --> Oct 2027
Enrollment open • Phase classification • Trial completion date • Trial primary completion date
|
modafinil
4ms
New P2 trial
|
modafinil
4ms
LC: Investigation of Locus Coeruleus Function in Sustained Attention (clinicaltrials.gov)
P4, N=40, Recruiting, University of California, Davis | Trial primary completion date: Aug 2025 --> Dec 2025
Trial primary completion date
|
modafinil
4ms
COSTEP 1: Cognitive Strategies in Early Psychosis 1 (clinicaltrials.gov)
P3, N=103, Recruiting, University of Minnesota | Not yet recruiting --> Recruiting
Enrollment open
|
modafinil
4ms
COSTEP 2: Cognitive Strategies in Early Psychosis 2 (clinicaltrials.gov)
P3, N=24, Not yet recruiting, University of Minnesota
New P3 trial
|
modafinil
5ms
COSTEP 1: Cognitive Strategies in Early Psychosis 1 (clinicaltrials.gov)
P3, N=103, Not yet recruiting, University of Minnesota
New P3 trial
|
modafinil
8ms
MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis (clinicaltrials.gov)
P2, N=64, Recruiting, Clinical Academic Center (2CA-Braga) | Trial completion date: Feb 2025 --> Sep 2026 | Trial primary completion date: Feb 2025 --> Jun 2026
Trial completion date • Trial primary completion date
|
modafinil
12ms
RECOVER-SLEEP: Platform Protocol (clinicaltrials.gov)
P2, N=1074, Recruiting, Duke University | Trial completion date: Jul 2025 --> Dec 2025 | Trial primary completion date: Jul 2025 --> Dec 2025
Trial completion date • Trial primary completion date
|
modafinil